LEGEND BIOTECH CORP-ADR (LEGN) Stock Balance Sheet
NASDAQ:LEGN - US52490G1022 - ADR
36.08 USD
+1.09 (+3.12%)
36.08 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 266.59M | 286.75M | 1.28B | 786.00M | 688.90M | |||
| Marketable Securities | 701.04M | 836.00M | 31.36M | 240.90M | 194.90M | |||
| Receivables | 228.99M | 124.89M | 157.06M | 45.50M | 58.30M | |||
| Inventories | 35.59M | 23.90M | 19.43M | 10.40M | 1.70M | |||
| Other Current Assets | 17.67M | 12.37M | 12.23M | 16.30M | 5.90M | |||
| Total Current Assets | 1.25B | 1.28B | 1.50B | 1.10B | 949.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 233.60M | 201.22M | 189.23M | 160.80M | 140.80M | |||
| Intangibles | 2.14M | 2.16M | 4.06M | 3.40M | 4.70M | |||
| Other Non-Current Assets | 204.31M | 182.48M | 156.79M | 66.80M | 22.00M | |||
| Total Non-Current Assets | 440.04M | 386.24M | 350.81M | 231.90M | 169.60M | |||
| TOTAL ASSETS | 1.69B | 1.67B | 1.85B | 1.33B | 1.12B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.91M | 4.79M | 3.17M | 3.60M | 900.00K | |||
| Accrued Expenses | N/A | 59.53M | 102.44M | 149.30M | 100.60M | |||
| Accounts Payable | 214.20M | 204.77M | 152.96M | 32.90M | 7.00M | |||
| Other Current Liabilities | 45.38M | 174.72M | 90.65M | 112.10M | 120.70M | |||
| Total Current Liabilities | 265.48M | 277.64M | 216.42M | 297.80M | 229.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 382.01M | 345.81M | 325.50M | 281.00M | 122.10M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 6.89M | 6.15M | 55.32M | 7.90M | 2.30M | |||
| Total Non-Current Liabilities | 388.89M | 351.96M | 380.82M | 288.90M | 124.30M | |||
| TOTAL LIABILITIES | 654.38M | 629.61M | 597.24M | 586.70M | 353.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 1.04B | 1.04B | 1.25B | 744.30M | 765.90M | |||
| Common Shares | 37.00K | 37.00K | 36.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 183.88M | 182.97M | 181.23M | 164.44M | 166.69M | |||
| Tangible Book Value per Share | 2.80 | 2.83 | 3.43 | 2.24 | 761.26 | |||
| Total Shareholders' Equity | 1.04B | 1.04B | 1.25B | 744.30M | 765.90M | |||
| TOTAL LIABILITIES AND EQUITY | 1.69B | 1.67B | 1.85B | 1.33B | 1.12B | |||
| Statistics | ||||||||
| Debt/Equity | 0.37 | 0.33 | 0.26 | 0.38 | 0.16 | |||
| Current Ratio | 4.71 | 4.62 | 6.92 | 3.69 | 4.14 | |||
| Return On Assets (ROA) | -19.25% | -10.60% | -28.03% | -33.53% | -36.05% | |||
| Return On Equity (ROE) | -31.42% | -17.01% | -41.41% | -59.96% | -52.70% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21